ML19353C717

From kanterella
Jump to navigation Jump to search
Letter to Gregory Piefer, Regarding Environmental Site Audit Regarding Shine Medical Technologies, LLC - Proposed Medical Isotope Production Facility
ML19353C717
Person / Time
Site: SHINE Medical Technologies
Issue date: 12/19/2019
From: Jennifer Davis
NRC/NMSS/DREFS/ENRB
To: Piefer G
SHINE Medical Technologies
Davis J
Shared Package
ML19353C687 List:
References
Download: ML19353C717 (2)


Text

2 UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 December 19, 2019 Gregory Piefer, Ph.D.

Chief Executive Officer SHINE Medical Technologies, LLC 101 E. Milwaukee Street, Suite 600 Janesville, WI 53545

SUBJECT:

ENVIRONMENTAL SITE AUDIT REGARDING SHINE MEDICAL TECHNOLOGIES, LLC - PROPOSED MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)

Dear Dr. Piefer:

The U.S. Nuclear Regulatory Commission (NRC) staff is reviewing the SHINE Medical Technologies, LLC (SHINE) application for an operating license for a proposed medical isotope production facility in Janesville, Wisconsin. As part of the environmental review, an environmental site audit will be conducted by the NRC staff during the week of February 3, 2020. The environmental audit activities will be conducted in accordance with the enclosed environmental audit plan (Enclosure 1).

To aid in developing the supplement to NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, (Agencywide Documents Access and Management System Accession Number ML15288A046), the NRC staff requests that the information described in the enclosed environmental audit needs list (Enclosure 2) be made available during the environmental site audit. A draft schedule of tours and meetings for the audit is also provided (Enclosure 3). The NRC staff informally transmitted this information to your staff, Mr. Jeff Barteleme, by e-mails dated December 6, 2019 and December 16, 2019.

If you have any questions, please contact me by telephone at 301-415-3835 or by e-mail at Jennifer.Davis@nrc.gov.

Sincerely,

/RA/

Jennifer Davis, Senior Project Manager Division of Rulemaking, Environmental and Financial Support Office of Nuclear Material Safety and Safeguards Docket No.: 50-608

Enclosures:

As stated cc w/ encl.: See next page

G. Piefer 2

SUBJECT:

ENVIRONMENTAL SITE AUDIT REGARDING SHINE MEDICAL TECHNOLOGIES, LLC -PROPOSED MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NUMBER: 50-608)

Dated: December 19, 2019 DISTRIBUTION:

Public RidsNrrDanu RidsNrrDanunplb RidsNmssRefs RidsACRS_MailCTR RidsOgcMailCenter RidsOpaMail RidsOCAMailCenter RElliot, NMSS JDavis, NMSS NMartinez, NMSS GCasto, NRR SLynch, NRR LTran, NRR MBalazik, NRR JLynch, RIII CFrazier, RIII HLogaras, RIII ABarker, RIII VMitlyng, RIII JPelchat, RII ADAMS Package Accession Nos.: ML19353C687

  • via e-mail OFFICE NMSS/REFS/ERLB NMSS/REFS/ERMB NMSS/REFS/ENRB NMSS/REFS/ERLB NAME *NMartinez *AWalker-Smith JDavis *RElliott DATE 12/19/19 12/19/19 12/19/19 12/19/19 OFFICIAL RECORD COPY